- Home
- ARMP vs FSI Comparison
ARMP vs FSI Comparison
Compare ARMP & FSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARMP
- FSI
- Stock Information
- Founded
- ARMP N/A
- FSI 1991
- Country
- ARMP United States
- FSI Canada
- Employees
- ARMP N/A
- FSI N/A
- Industry
- ARMP Biotechnology: Biological Products (No Diagnostic Substances)
- FSI Recreational Games/Products/Toys
- Sector
- ARMP Health Care
- FSI Consumer Discretionary
- Exchange
- ARMP Nasdaq
- FSI Nasdaq
- Market Cap
- ARMP 52.1M
- FSI 55.6M
- IPO Year
- ARMP N/A
- FSI 1999
- Fundamental
- Price
- ARMP $2.22
- FSI $5.74
- Analyst Decision
- ARMP Strong Buy
- FSI
- Analyst Count
- ARMP 1
- FSI 0
- Target Price
- ARMP $9.00
- FSI N/A
- AVG Volume (30 Days)
- ARMP 18.4K
- FSI 21.5K
- Earning Date
- ARMP 08-12-2025
- FSI 08-13-2025
- Dividend Yield
- ARMP N/A
- FSI 1.71%
- EPS Growth
- ARMP N/A
- FSI N/A
- EPS
- ARMP N/A
- FSI 0.18
- Revenue
- ARMP $4,699,000.00
- FSI $36,483,680.00
- Revenue This Year
- ARMP $8.43
- FSI $21.91
- Revenue Next Year
- ARMP N/A
- FSI $42.35
- P/E Ratio
- ARMP N/A
- FSI $31.62
- Revenue Growth
- ARMP 14.24
- FSI N/A
- 52 Week Low
- ARMP $0.90
- FSI $1.65
- 52 Week High
- ARMP $3.42
- FSI $7.24
- Technical
- Relative Strength Index (RSI)
- ARMP 63.56
- FSI 68.78
- Support Level
- ARMP $1.93
- FSI $5.52
- Resistance Level
- ARMP $2.24
- FSI $6.10
- Average True Range (ATR)
- ARMP 0.16
- FSI 0.28
- MACD
- ARMP 0.03
- FSI 0.11
- Stochastic Oscillator
- ARMP 104.55
- FSI 80.54
About ARMP Armata Pharmaceuticals Inc.
Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.
About FSI Flexible Solutions International Inc. (CDA)
Flexible Solutions International Inc develops, manufactures, and markets specialty chemicals that slow the evaporation of water. Its business is organized into two segments: Energy and Water Conservation Products and Biodegradable Polymers. It offers a liquid swimming pool blanket under the WATERSAVR brand, which saves energy and water by inhibiting evaporation from the pool surface, and a chemical product called HEATSAV for use in swimming pools and spas to slow water evaporation. The firm also manufactures and markets water-soluble chemicals utilizing thermal polyaspartate biopolymers. It generates the majority of its revenues from the export of its products to international markets.